Alsaadi, J.H.H. 2025. Interferon-Beta-1a (Rebif) a Risk Factor on Liver, Kidney and Sex Hormones with Multiple Sclerosis Patients: A Review. American Journal of Biomedicine and Pharmacy. 2, 4 (Apr. 2025), 1–13.